File(s) under permanent embargo
The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome
journal contribution
posted on 2000-03-05, 00:00 authored by Tania De Koning-WardTania De Koning-Ward, D A Fidock, V Thathy, R Menard, R M L van Spaendonk, A P Waters, C J JanseGenetic transformation of malaria parasites has been limited by the number of selectable markers available. For the rodent malaria parasite, Plasmodium berghei, only a single selection marker has been at hand, utilising the dihydrofolate reductase-thymidylate synthase gene from either P. berghei or Toxoplasma gondii to confer resistance to the anti-malarial drug pyrimethamine. Here we report the use of the human dihydrofolate reductase (hDHFR) gene as a new selectable marker, which confers resistance to the antifolate inhibitor WR99210 upon both pyrimethamine sensitive and resistant isolates of P. berghei. Transfection with circular constructs containing the hDHFR gene resulted in the generation of highly resistant parasites containing multiple copies of episomally-maintained plasmids. These parasites showed around a 1000-fold increase in resistance to WR99210 compared to the parental parasites. We were also able to generate and select transgenic parasites harbouring only a single copy of hDHFR targeted into their genome, despite the fact that these parasites showed only a fivefold increase in resistance to WR99210 compared to the parental parasites. Importantly, and for the first time with malaria parasites, the hDHFR gene could be used in conjunction with the existing pyrimethamine selectable markers. This was demonstrated by reintroducing the circumsporozoite (CS) gene into transgenic CS-knockout mutant parasites that contained the P. berghei DHFR-TS selectable marker. The development of hDHFR as a second selectable marker will greatly expand the use of transformation technology in Plasmodium, enabling more extensive genetic manipulation and thus facilitating more comprehensive studies on the biology of the malaria parasite.
History
Journal
Molecular and biochemical parasitologyVolume
106Issue
2Pagination
199 - 212Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
0166-6851Language
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2000, Published by Elsevier Science B.V.Usage metrics
Categories
No categories selectedKeywords
AnimalsAnimals, Genetically ModifiedAntimalarialsBase SequenceDNA PrimersDrug ResistanceFolic Acid AntagonistsGenetic MarkersGenome, ProtozoanHumansPlasmidsPlasmodium bergheiProtozoan ProteinsPyrimethamineTetrahydrofolate DehydrogenaseTransfectionTriazinesScience & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyParasitologyhuman DHFRcircumsporozoite proteinselection markerMALARIA PARASITESBLOOD STAGESANTIMALARIAL ACTIVITYFALCIPARUMEXPRESSIONWR99210PROTEINTRANSFORMATIONSPOROZOITES
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC